Fund Holdings — GREAT POINT PARTNERS LLC

Total Portfolio Value
$424.45M
Total Bought
$153.83M
Total Sold
$159.64M
Net Transaction
-$5.81M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
ABIVAX SA(ABVX)0204,314+204,314027,2276.41%+27,227
DEFINIUM THERAPEUTICS INC(DFTX)0425,000+425,000019,9924.71%+19,992
VERA THERAPEUTICS INC(VERA)199,348600,836+401,4888,02025,7826.07%+17,762
SAGIMET BIOSCIENCES INC(SGMT)02,029,933+2,029,933015,6913.70%+15,691
IMMIX BIOPHARMA INC(IMMX)350,0001,277,642+927,6423,18913,1723.10%+9,984
ORUKA THERAPEUTICS INC(ORKA)183,330183,33008,99217,4484.11%+8,455
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)500,000855,813+355,8139,32016,6633.93%+7,343
INFLARX NV(IFRX)03,046,557+3,046,55706,8241.61%+6,824
OPUS GENETICS INC(IRD)324,3401,970,187+1,645,8471,4768,0971.91%+6,622
ANNEXON INC(ANNX)2,500,0003,500,000+1,000,00013,85019,9854.71%+6,135
JATT II ACQUISITION CORP0500,000+500,00005,6801.34%+5,680
ALTIMMUNE INC(ALT)01,741,232+1,741,23205,2931.25%+5,293
ALUMIS INC856,061856,061018,85924,0905.68%+5,231
AMANAT ACQUISITION CORP0500,000+500,00005,0801.20%+5,080
CONTINEUM THERAPEUTICS INC(CTNM)800,198921,481+121,28310,45115,1033.56%+4,652
CLIMB BIO INC(CLYM)1,334,1301,000,000-334,1309,13913,0403.07%+3,901
SCYNEXIS INC0944,292+944,29203,8430.91%+3,843
ENLIVEN THERAPEUTICS INC070,000+70,00003,5530.84%+3,553
LB PHARMACEUTICALS INC(LBRX)300,000317,221+17,2217,39810,2952.43%+2,897
REIN THERAPEUTICS INC(RNTX)02,575,000+2,575,00002,6780.63%+2,678
DBV TECHNOLOGIES S A(DBVT)0156,906+156,90602,5730.61%+2,573
REZOLUTE INC(RZLT)951,809951,80902,9034,9491.17%+2,046
CULLINAN THERAPEUTICS INC(CGEM)300,000300,00004,2635,4631.29%+1,200
NEUROGENE INC(NGNE)500,000352,180-147,82010,08011,0762.61%+996
HUMACYTE INC(HUMA)3,750,0003,750,00002,2752,9270.69%+651
VOR BIOPHARMA INC(VOR)1,750,0001,700,000-50,00031,22031,2977.37%+77
RELMADA THERAPEUTICS INC(RLMD)842,106842,10605,8615,8271.37%-34
ZURA BIO LTD(ZURA)4,215,9304,215,930025,08524,8745.86%-211
SILENCE THERAPEUTICS PLC(SLN)1,020,489450,000-570,4895,3784,9411.16%-437
EUPRAXIA PHARMACEUTICALS INC(EPRX)1,200,0001,200,00008,6887,9321.87%-756
PALISADE BIO INC(PALI)3,405,7572,284,819-1,120,9385,9604,7751.13%-1,185
SOL-GEL TECHNOLOGIES LTD
SHS NEW
274,363274,363021,73520,3414.79%-1,394
ALKERMES PLC(ALKS)50,0000-50,0001,7680—-1,768
AVALO THERAPEUTICS INC(AVTX)124,6660-124,6661,8610—-1,861
PHARVARIS N V
COM
82,8000-82,8002,3390—-2,339
EVOMMUNE INC(EVMN)325,000325,00007,4724,3191.02%-3,152
PROMIS NEUROSCIENCES INC(PMN)371,40286,150-285,2524,7171,1340.27%-3,583
TENAX THERAPEUTICS INC(TENX)327,3070-327,3075,2340—-5,234
UNICYCIVE THERAPEUTICS INC(UNCY)796,5580-796,5585,2410—-5,241
CONTEXT THERAPEUTICS INC(CNTX)2,238,4960-2,238,4965,8650—-5,865
SCYNEXIS INC(SCYX)7,554,3470-7,554,3476,9270—-6,927
COMPASS THERAPEUTICS INC(CMPX)1,350,0000-1,350,0007,1420—-7,141
BRIGHT MINDS BIOSCIENCES INC(DRUG)220,000109,603-110,39716,0537,6941.81%-8,359
ZENAS BIOPHARMA INC(ZBIO)524,0660-524,06610,2450—-10,245
NEKTAR THERAPEUTICS(NKTR)316,453175,000-141,45322,76912,2172.88%-10,552
AMYLYX PHARMACEUTICALS INC(AMLX)1,750,000700,000-1,050,00024,32512,5722.96%-11,753
JADE BIOSCIENCES INC964,4620-964,46213,5510—-13,551
IMMUNOVANT INC(IMVT)545,6250-545,62513,5530—-13,553
KALVISTA PHARMACEUTICALS INC675,0000-675,00013,5880—-13,588
APOGEE THERAPEUTICS INC(APGE)374,0000-374,00031,4800—-31,480
Page 1 of 1
GREAT POINT PARTNERS LLC — 13F Holdings — Q2 2026 | TickerTrail